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1. Introduction  
Flax (Linum usitatissimum) is an important crop plant that is widely distributed in the 
Mediterranean and temperate climate zones. It has great significance for industry as a 
valuable source of oil and fibres. A unique feature of flax is the possibility of whole plant 
exploitation with almost no waste products. For this reason, flax has quite significant 
potential for biotechnological application. To increase the valuable qualities of flax products, 
the flax genome has been genetically modified, with the specific aims to improve the plant’s 
pathogen resistance, taste and nutritional properties, and to produce pharmaceuticals and 
other compounds. In this chapter, we describe the plant characteristics that show the 
biochemical and industrial importance of flax oil and fibres and their various possible 
applications and the relevant genetic modifications. 
Since ancient times, flax has been known to be a source of oil and fibres, and it has been 
cultivated as a dual-purpose plant for a long time. Nowadays, it is a multi-purpose plant 
and its exploitation is not restricted to the production of linen fibre and oil. Actually, whole 
plant exploitation is possible, which justifies the name given to it by Linnaeus: L. 
usitatissimum, meaning “useful flax”. There is a wide range of possible applications of flax 
(Fig.1). The long fibres are used in the textile industry, and the short fibres in paper 
production, isolation materials and biocomposite production. The wooden shives released 
during flax scutching can serve as an energy source. Flax seeds also have many important 
applications, and due to its high nutritional value, it is used in the food, pharmaceutical and 
health care industries. The seedcake, which is rich in antioxidants, is used in the 
pharmaceutical and cosmetic industries.  
The development of molecular biology emerged as an important tool for the genetic 
modification of plants, and enabled the improvement of many different features of wild type 
plants. These modifications broadened the range of practical applications for flax, making the 
plant more valuable and more significant for the innovative biotechnological industry. 
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Fig. 1. The multipurpose application of flax 
Flax is a good source of unsaturated fatty acids, dietary fibre and another nutrients. It is 
composed mainly of fat (41%), protein (20%) and dietary fibre (28%). The contents may vary 
depending on genetics, environment, seed processing and the analysis method. Linum 
usitatissimum is the best-known species with a high concentration of ǂ-linolenic acid (ALA). 
Polyunsaturated fatty acids compose about 73% of the total fatty acid content. Flax proteins 
are rich in arginine, aspartic acid and glutamic acid. Linum usitatissimum is characterized 
with a high content of polysaccharidic mucilage. It confers from 6 to 8% of the dry weight. 
The acidic polysaccharide consists of L-rhamnose, L-galactose and D-galacturonic acid and 
the neutral polysaccharides L-arabinose, D-xylose and D-galactose. The amino acid 
composition of flax indicates that the most abundant are glutamic acid, aspartic acid and 
arginine. Moreover a series of cyclic polypeptides, which contains between eight and ten 
amino acids, have been identified in Linum usitatissimum. Some of them exhibit 
immunosuppressive activity. Phytochemicals that have been identified in flax mainly 
consist of lignans, isoprenoids, phenolic acids, flavonoids and cyanogenic glucosides. All 
these compounds, apart from cyanogenic glucosides are known to have antioxidant 
properties or inhibitory activity against carcinogen induced tumors. 
2. Flax fibre quality improvement and its biomedical application 
Flax fibres have many useful applications. They are flexible, lustrous and soft. Moreover, 
flax fibres are stronger than cotton but less elastic. They absorb humidity and are allergen-
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free. These properties make flax fibres useful in the textile industry but they are also used in 
the manufacture of car-door panels, plant pots and retaining mats. Recently, some research 
has been carried out to improve the quality of flax fibres and make them suitable for the 
biomedical industry. Innovative flax fibre-containing products have been developed with 
potential applications in the medical field. The main strategy was to make use of genetically 
modified flax fibres with unusual and unique properties. 
2.1 Fibre quality improvement 
Flax is a great source of fibre. Plant fibres are divided into three groups: the phloem stem 
fibres (phloem stem fibres or xylem stem fibres) of dicotyledonous plants; the leaf fibres of 
monocotyledonous plants; and the seed and fruit fibres (Ilvessalo-Pfaffli, 1995). Flax fibres 
belong to the first group.  
The flax stem is 70% composed of cellulose. These hollow tubes grow together as bundles 
and are held by complex carbohydrates such as pectins, gums and waxes. These function as 
a plant support. The fibre separation process from the non-fibre tissues is called retting 
(Antonov et al., 2007). Retting is mainly the enzymatic action of polygalacturonase, which 
degradates the pectin polymers of the middle lamella into soluble galacturonic acid. This 
process is mainly carried out by plant pathogens like filamentous fungi. To obtain high-
quality fibres, the proper degree of retting is necessary (Zhang et al., 2000). The efficiency of 
retting depends on the method used, but traditional dew retting is still the most widely 
performed method. In this method, the flax stalks are left in the field after the harvesting of 
the flax seeds, and the soil microorganisms digest the cell matrix polysaccharides. The dew 
retting method is weather dependent, which makes it uncontrollable.  
The chemical composition of the flax stems can affect the degree of retting. Fibres which 
have more lignins need a longer period of retting. However, a longer exposure to fungal and 
bacterial enzymes decomposes the cellulose and weakens the fibres. One solution to this 
problem is to harvest the flax before seed maturity when the level of stem lignification is still 
low. Another solution is to genetically manipulate the flax, yielding an improved retting 
process. It is known that the pectin and hemicellulose contents of the fibres influence the 
fibre processing. A new technology to modify the biosynthesis and degradation of pectins 
with beneficial consequences for the flax fibre properties has been recently developed. The 
flax plant was transformed with Aspergillus aculeatus genes coding for polygalacturonase 
(PGI) or rhamnogalacturonase (RHA), which are the enzymes required to break down 
pectin of the flax fibres. The transformants were characterized by an increased enzyme 
activity and a significant reduction of pectin content. The reduction in pectin content was in 
the range of 56–68% for both the PGI and RHA plants. These results correlated with the 
retting efficiency, which was more than 2-fold higher in the transgenic flax than in the 
control plants (Musialak et al., 2007). Interestingly, the overexpression of the enzymes did 
not affect the fibre composition. No changes in the lignin or cellulose contents was observed 
in comparison to the control. Similarly, the levels of soluble sugars and starch were at the 
same levels as in the non-transformed flax. As the biochemical parameters of the cell wall 
components remained similar to those for the control plants and the fibre quality did not 
change, it is suggested that these modifications might be important for industrial and 
medical application. 
Another strategy of improving flax fibre quality was reducing the level of lignin synthesis. 
Lignins are complex polymers of three aromatic alcohols: coniferyl, sinapyl and p-coumaryl 
(Amthor, 2003), and cinnamyl alcohol dehydrogenase (CAD) is an enzyme that catalyses the 
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biosynthesis of lignin monomers (hydroxycinnamoylalcohols) from the corresponding 
aldehydes. CAD is the specific marker of lignification (Barakat et al., 2009). Flax fibres 
comprise 3-5% lignins, and they are mainly responsible for mechanical resistance. They 
create a physical barrier against pathogen infection, and are highly accumulated and 
deposited in response to pathogen attack (Tobias et al., 2005). The accumulation of lignins 
negatively influences the retting efficiency. To overcome this problem, transgenic flax with a 
silenced cad gene was created. In the generated plants, the CAD enzyme activity was 20-40% 
lower, and the lignin level decreased by up to 40 % (Wróbel- Kwiatkowska et al., 2006). 
Moreover, this modification influenced the composition of the cell wall. The pectin content 
and the hemicellulose content was significantly lower. Decreasing the level of the above-
mentioned compounds facilitated the retting process. Furthermore, the mechanical 
properties of the modified fibres were strongly improved, as the ratio of cellulose to lignin 
increased. Cellulose is the fibrous component of the cell wall, and the hemicellulose, pectins 
and lignins are the matrix components. An increased proportion of the fibrous to matrix 
components is the reason for the improvements in the mechanical properties of the stem. 
This data indicates that via genetic modification, it is possible to improve the mechanical 
properties of flax fibres and make them more useful for further application. 
2.2 Biodegradable flax biocomposite material as a new medical polymer 
Composites are materials made of matrix reinforced with natural fibres, and the term 
biocomposites is used for composites employed in bioengineering (Ramakrishna et al., 2004). 
The development of biocomposites is attractive because the properties of two or more types 
of material can be combined, which influences the properties of the composites. Most 
medical devices used in medicine and made of a single material, such as a polymer, metal or 
ceramic, are too flexible or too weak or too stiff to host tissues, and some may also be 
sensitive to corrosion or cause allergic reactions (e.g. nickel and chromium). All these 
disadvantages led to the development of composite materials for medical use. Nowadays, 
composites are used in numerous biomedical applications: sutures, cardiovascular patches, 
wound dressings, regeneration devices and tissue engineering scaffolds (Misra et al., 2006). 
Many composites have poor biomechanical properties and poor bioactivities. The 
composites containing biodegradable polymers can be divided into two groups: one based 
on natural polymers (e.g. starch, alginate, silk) containing as reinforcement natural fibres 
(lignocellulosic or cellulosic fibres); and the second based on synthetic polymers (polylactic 
acid PLA, polyglicolic acid PGA, poly-ε-caprolactone PCL) (Rezwan et al., 2006). Natural 
fibres replace glass, ceramics or carbon fibres (Bax and Mussig, 2008). In the last decade 
biocomposites were used by the automotive industry for door panels, seat backs, headrests 
and package trays among other things (Fig. 2), (Suddel et al., 2003;  Bledzki et al., 2006). 
Biocomposites have favourable biomechanical properties and they can also have bioactive 
properties, for example antioxidative and bacteriostatic action. The main problem in 
preparing biocomposites is often the poor adhesion between the matrix and the fibres used 
as reinforcement. This influences the mechanical properties of the composites and remains a 
significant disadvantage. Better contact between the fibres and the matrix also enhances the 
hydrophobicity of the composite. The possible solution to this problem might be the 
production of a biocomposite containing transgenic flax fibres enriched with hydrophobic 
and thermoplastic poly-ǃ-hydroxybutyrate (PHB). This non-toxic and water-insoluble 
compound displays chemical and physical properties similar to polypropylene. PHB is a 
biodegradable, ecologically friendly compound, and may be an alternative to conventional  
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Fig. 2. Applications of biocomposites in industrial products 
plastics used as the matrix component of composites, particularly those reinforced with 
fibres of natural origin (Peijs, 2002). PHB was discovered in the bacterium Bacillus 
megaterium and is found in other species of bacteria, including Alcaligenes, Azotobacter, 
Bacillus, Nocardia, Pseudomonas and Rhizobium. It is synthesized in a three-step reaction 
catalysed by ǃ-ketothiolase (phbA), acetoacetyl-CoA reductase (phbB) and by PHB synthase 
(phbC) (Fig. 3), (Steinbuchel and Fuchtenbusch, 1998). In bacteria, PHB serves as a source of 
carbon and energy. 
Isolating PHB from bacteria is expensive, so producing PHB in plants could be a promising 
method. Transgenic flax plants with overexpression of the three genes encoding PHB 
synthesis have been generated, and shown to be useful for biomedical applications. The 
stem-specific 14-3-3 promoter was used for the transformation. Three genes coding for ǃ-
ketothiolase, acetoacetyl-CoA reductase and PHB synthase were derived from R. eutropha. 
The generated plants (named M plants) exhibited a PHB content of up to 4.62 µg/gFW 
(Wróbel et al., 2004). The electron-lucent granules of PHB were detected in the stroma of the 
plastids in the M plants. Moreover, the PHB synthesis affected the shape and size of the 
chloroplasts: the diameter of chloroplast increased, and they were characterized by a more 
oval shape. The accumulation of PHB resulted in changes in the stem’s mechanical properties. 
These properties were measured using Young’s modulus. This parameter was two-fold higher 
in the M plants, which indicates that transgenic fibres enriched with PHB have a higher 
average resistance to tensile loads and better elastic properties. The fibre composition of the M 
plants was examined using the infrared (IR) spectra method.  
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Fig. 3. Polyhydroxybutyrate (PHB) synthesis pathway 
The greater structural disorder of the M fibres resulted from the formation of celluloses with 
an amorphous structure and from the shortening of the cellulose chain lengths. What is 
more, the M plants exhibited stronger coupling between the elementary fibres, which made 
them more stable (Wróbel- Kwiatkowska et al., 2009). Introducing PHB to flax fibres yielded 
the commercially utilized bast fibres. Fibres derived from those plants can be particularly 
used as the reinforcement in biocomposites (Fig.4). 
First of all, the PHB in those fibres improves the adhesion between the fibres and the matrix, 
and secondly, such fibres remain a great source of phenolic acids, which possess 
antioxidative properties that are especially important when the fibres are used for medical 
purposes. Previous studies showed that composites of transgenic flax fibres enriched with 
PHB and polypropylene do not promote platelet aggregations in contrast to pure 
polypropylene (Szopa et al., 2009). It was also noticed that those transgenic fibres have 
bacteriostatic properties (data not published).  
A new generation of entirely biodegradable composites were made of polylactic acid (PLA) 
and alternatively of poly-ε-caprolactone (PCL) enriched with bioplastic flax fibres. 
Determining the level of platelet aggregations on the surface of the prepared composites and 
the level of colonization of bacteria (E. coli) to their surfaces showed the composites’ anti-
aggregational and bacteriostatic properties. The new composites also exhibited improved 
biomechanical properties in comparison to membranes made of pure PLA or PCL, and good 
in vitro biocompatibility, even though the cell viability of mouse fibroblast cells treated with  
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Fig. 4. Biodegradable flax composites made of polypropylene (PP) enriched with different 
content of bioplastic flax fibres (M plants). The control composite is made of polypropylene 
with no addition of flax fibres 
these composites was slightly reduced and the amount of dead cells also slightly increased 
when compared to untreated cells (Gredes et al., 2010). It was also shown that implanting 
the tested biocomposites based on PLA and transgenic flax fibres into rat skeletal muscle 
had no influence on the gene expression of the most analysed genes, i.e. vascular endothelial 
growth factor (VEGF), insulin-like growth factor (IGF) and growth differentiation factor 8 
(GDF8) (Gredes et al., 2010). The used implants composed of transgenic plastic fibres in a 
PLA matrix showed better biocompatibility than pure PLA or PHB implants, and they did 
not have any negative effect on muscle function and gene expression. Thus, the new 
biocomposites created with bioplastic flax fibres might be considered as a new material for 
tissue engineering and other branches of medicine. 
2.3 The new bandage based on transgenic flax products 
The number of patients with serious ulcer wounds is still increasing. This is a consequence 
of chronic diseases such as diabetes, obesity and atherosclerosis. An ulcer that is considered 
chronic, or non-healing, is one which takes more than eight weeks to heal despite optimal 
local and general treatment. Wound healing is a complex and dynamic process, divided into 
three overlapping stage: cleaning, proliferation, and wound constriction and cicatrisation. 
The complex treatment of ulcers mainly consists of wound diagnostics, casual treatment 
directed at the primary disease, the exclusion of other factors that inhibit healing processes, 
and general and local treatment (Abbade & Lastória, 2005). There are many factors that can 
influence wound healing, and using a proper wound dressing is among them. In recent 
years, many different specialized wound dressings were developed, such as 
hydroxycellulose, hydrocolloid, polyuretic-foam dressing, alginans, hydrogel dressing and 
dressing containing silver (Jones et al., 2006; Skórkowska-Telichowska et al., 2009). The 
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purpose of a dressing is to isolate the wound, keep it at an optimal moisture level, remove 
excess exudates, help clean the wound of debris and necrotic tissue, help combat 
microbiological infection when necessary, and stimulate tissue regeneration.  
One recently proposed wound dressing is made from genetically modified flax fabric (Fig.5). 
Flax has been used since ancient times for the production of linen cloth widely used for 
making clothes that are especially useful in humid climates due to certain flax fibre 
properties, the effects of which are called “wicking”. This refers to their capillary action, 
which channels moisture away from the body (Muir & Westcott, 2003). This makes flax an 
attractive material for wound dressing, as it may be useful in keeping the wound at the 
optimal moisture level. Additionally, the loose weave of flax tissue enables wound 
purification from various contaminations. 
 
 
Fig. 5. Scheme of flax dressing 
The biotechnological engineering was used to improve the flax fibres for medicinal use. 
After it was suggested that reactive oxygen species are responsible for chronic wound 
pathogenesis and anti-healing processes because they reduce the cell proliferation capacity 
(Chen et al., 2004; Wall et al., 2008), the use of flax fibres enriched in antioxidants in making 
of a wound dressing was proposed. Oxidative stress causes damage to cellular 
macromolecules; the deregulation of key proteins involved in DNA replication, the cell 
cycle, and cellular resistance to such stress; and the promotion of wound fibroblast 
apoptosis. Antioxidant-rich flax plants called W92 were created using three genes 
controlling the synthesis of plant secondary metabolites from the phenylopropanoid 
pathway: chalcone synthase, chalcone isomerase, and dihydroflavonol reductase. The 
introduction of those genes resulted in the accumulation of various antioxidative 
compounds like flavonoids, phenolic acids and lignans in the plant seeds and fibres (Lorenc-
Kukuła et al., 2005). The antioxidant properties of these compounds might have a great 
significance for wound healing, because they inhibit enzymatic and non-enzymatic 
peroxidation. Flavonoids and phenolic acids also exhibit anti-inflammatory, antihistamine, 
antiviral and vasodilatory properties. It is suggested that the high level of 
phenylopropanoid compounds strengthens wound tissue defenses against biotic and abiotic 
stresses (Afaq et al., 2007; Chiang et al., 2005; Bae et al., 2009). The simultaneous use of 
www.intechopen.com
Flax Engineering for Biomedical Application 
 
415 
fibres, oil emulsion and seedcake extract from genetically modified flax plants promoted the 
healing of chronic skin ulcerations (Skórkowska-Telichowska et al., 2010). In the pilot 
clinical trial, 30 patients with chronic skin ulceration (having lasted from 2 to 23 years) were 
treated with a linen dressing for 12 weeks. The treatment was divided into three phases: the 
dry phase with use of a highly hygroscopic linen dressing aimed at drying and cleaning the 
wounds; the second stage with linen dressing wetted with an oil emulsion derived from 
transgenic flax, with the aim to supply the wounds with polyunsaturated fatty acids (PUFA) 
and antioxidants; and the third stage with flax bandages wetted with seedcake extract rich 
in lignans, which are anti-inflammatory and cell proliferation promoting compounds. Such 
treatment effectively reduced the wound exudates in almost 67% of the subjects. Moreover, 
93% of the patients exhibited a decrease in the fibrin level, which is one of the steps in 
wound healing. An important and objective parameter that was assessed was the wound 
size, and it emerged that in 80% of the patients, the ulcer size was reduced, of which 23% 
were totally cured (Fig.6). Interestingly and importantly, the bandage diminished the pain 
accompanying chronic venous ulceration as reported by patients.  
It is believed that the effectiveness of a flax wound dressing is thanks to: 
- the hygroscopic properties of the flax fibres providing an optimal moisture level and 
absorbing the excess of exudates; 
- the phenolic acid and flavonoid content in the flax fibres reducing the inflammation in 
the wound; 
- the unsaturated fatty acids which reinforce the integrity of the plasma membranes of 
the fibroblasts 
- the presence of lignans stimulating fibroblast proliferation;  
- the protection of the wound from mechanical irritation; 
- the wound being kept clean and insulated from necrotic elements and contamination 
that move beyond the dressing surface. 
Recently this new bandage, which is called Flax Aid, has become certified and is now 
offered by the Linum Foundation (www.leczenielnem.pl).  
There is a proposal to replace the linen dressings from W92 plants with dressings from M 
plants (bioplastic fibres) because the induction of cell proliferation is very important for 
wound healing. For this reason, polyhydroxybutyrate (PHB) has received particular interest. 
Upon contact with body fluids, the polymer degrades to release D,L-ǃ-hydroxybutyrate, 
promoting the proliferation of cells in high-density cultures by preventing apoptotic cell 
death (Cheng et al., 2006) making it an attractive candidate for tissue engineering 
applications, especially those requiring the regeneration of large numbers of cells as 
described in the previous section. The fabric, made from plants enriched in 
polyhydroxybutyrate (M plants), was tested for suitability as a wound dressing. In this case, 
only the first stage (flax fabric wetted with isotonic solution) was investigated and only the 
wound size was considered, and the results were compared to those obtained with the W92 
type dressing. During the four weeks of flax dressing treatment (twenty cases with chronic 
ulcerations of venous origin), the majority of the subjects treated with M flax bandages 
showed a statistically significant reduction in wound size. The average reduction in the 
ulcer size within this group was 28% (6 cm2), which is a far better result than that (7.78%) 
obtained for dressings prepared from the fibres of W92 plants. Thus, it is suggested that the 
fabric from the fibres of M plants is more effective in wound healing than that from W92 
plants. It should be pointed out that both transgenic fabrics inhibit the growth of pathogenic 
bacteria and fungi in in vitro studies and are more effective than control and cotton fibres. 
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Fig. 6. Foot ulcer before (A) and after (B) twelve- week treatment with flax dressing 
The antimicrobial activity of a flax fabric dressing is of great interest, as from clinical 
practice it is known that quite often long-term wounds can become infected. Very often this 
is caused by a antibiotic-resistant bacterial and fungal strains, so new ways to combat 
microbiological infections are needed. These results show that linen dressings obtained from 
GM flax have beneficial effects on wound healing and can be used as an innovative flax 
biotechnological product. 
3. Transgenic flax as a source of bioactive compounds designated for 
therapy and health-promoting actions 
Linseed oil has commercial value as a component of adhesives, paints and varnishes, 
plasticizers, inks and linoleum. It is also a precursor of nylon and composite materials. That 
said, the most important aspect for humans is the dietary properties of flax seeds. Linseed 
oil is one of the richest sources of ǂ-linolenic acid (ALA), with a content of 44–57%; it also 
contains 15–29% linoleic acid and 13–29% oleic acid (Muir and Westcott, 2003). As the 
human body cannot produce ALA, which belongs to the ω-3 family, it is an essential fatty 
acid in our diet. Therefore, linseed oil plays an important role in the food, health care and 
pharmaceutical industries. The unsaturated fatty acids of linseed oil have a positive 
influence on the metabolism and peristalsis. They can lower the total and LDL cholesterol 
and glucose levels in the blood (Pellizzon et al., 2007).  
The market value of linseed oil is limited by the lability of polyunsaturated fatty acids 
(PUFA), which are susceptible to peroxidation. Only a few cultivars of the flax with low 
A B
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PUFA contents are suitable for commercial use as an edible oil. The rancidity and the 
development of an undesirable odor in linseed oil is mainly caused by the interaction of 
reactive oxygen species (ROS) with PUFA. Lipid peroxidation degrades unsaturated fatty 
acids and leads to the accumulation of dangerous products. ROS are known to be associated 
with aging, inflammation, carcinogenesis and atherosclerosis (Choi et al., 2002). For this 
reason, the inactivation and elimination of ROS might be very beneficial not only in 
industrial but also in nutritional applications. To avoid oxidation, linseed oil is 
supplemented with vitamin E and stored in low temperature in dark bottles. However, 
these methods are not satisfactory. A promising strategy might be the genetic manipulation 
of flax to improve the oil quality and the stability of the PUFA, and thus the natural 
supplementation of protective antioxidant compounds in flax seeds. There are a few 
interesting approaches in which various antioxidant compounds were synthesized in 
transgenic plants. The goal of this research was to improve flax seed quality by increasing 
the level and stability of unsaturated fatty acids and antioxidant compounds via genetic 
engineering. The modifications were directed toward improving the beneficial effects of flax 
seeds. 
3.1 Manipulation of the flax genes of the phenylopropanoid pathway 
Breeding plants which are able to produce pharmaceuticals and other valuable compounds 
is one major reason for the genetic modification of plants. The phenylopropanoid pathway 
seems to be one of the most important metabolic pathways due to its involvement in the 
synthesis of a large range of natural products in plants, including lignans, lignin, flavonoids 
and anthocyanins. All of these compounds act as antioxidants, chelators of divalent cations, 
photoreceptors, and visual attractors. The pathway of flavonoid synthesis begins with 
chalcone synthesis catalysed by chalcone synthase (CHS) and flavonon and flavonol 
synthesis catalysed by chalcone isomerase (CHI), leading to flavan production in a reaction 
catalysed by dihydroflavonol reductase (DFR) (Fig.7). Flavan is direct precursor of 
anthocyanidins and proantocyanidins. The last step in flavonoid biosynthesis is their 
glycosylation by glycosyl transferase. The phenylopropanoid synthesis pathway is the 
source of different compounds of great biomedical application like phenolic acids, lignans 
catecholamines and lignins. 
Many phenolic compounds (lignans, phenolic acids) have been identified in both the green 
parts and the seeds of flax plants, which is the irrefutable proof of the presence of an active 
phenylopropanoid pathway in this plant. The enzymes of the phenylpropanoid pathway are 
appropriate targets for genetic manipulation, and the modulation of their levels alters the 
content of secondary metabolites. There are two alternative ways to increase the phenolic 
compound contents in plants: increase the expression of the key enzymes of synthesis; and 
overexpress the enzymes regulating stability of these compounds.  
The first strategy was used to create flax plants overexpressing three genes of the 
phenylopropanoid synthesis pathway: chalcone synthase (CHS), chalcone isomerase (CHI), 
and dihydroflavonol reductase (DFR). Such plants were characterized by a significant 
increase in the levels of flavonoids in the seeds, fibres and in the green parts of the plant 
(Lorenc-Kukuła et al., 2005). The major differences in the antioxidant levels were observed 
in the phenolic acid content, and more importantly for human consummates, flax seeds 
obtained from transgenic plants are rich in the strong antioxidants secoisolariciresinol 
diglucoside (SDG), kaempferol and quercetin. The results obtained for these plants are 
presented in Figure 8. 
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Fig. 7. The phenylopropanoid pathway 
A similar effect was obtained for flax plants with overproduction of glycosyltransferase (the 
second strategy), which resulted in higher accumulation of proanthocyanin, lignans and 
phenolic acids compared to the control (Lorenc-Kukuła et al., 2009) (Fig 8). Linseed oil is one 
of the richest sources of unsaturated fatty acids, especially ǂ-linolenic acid (ALA). 
Unfortunately, this product is unstable during long storage, because of the tendency to 
oxidation of fatty acids. Both modifications resulted in unsaturated fatty acid accumulation 
in the seeds. This observation suggests the involvement of polyphenol glycosides in the 
protection of unsaturated fatty acids against oxidation, which improves the oil.  
The genetic engineering approach could involve the overproduction of various natural 
antioxidants within the flax grains. In addition to preventing fat rancidity, antioxidants such 
as flavonoids might also have a beneficial effect on human health and such plants are a very 
good source of compounds for biomedical applications. Recently, there has been a growing 
interest in the probiotic properties of flax and in its beneficial effects on coronary heart 
disease, some types of cancer, and neurological and hormonal disorders (Saffron, 2008;  
Huang & Ziboch, 2001; Simopoulos, 2002). Flax seeds are the richest source of the plant 
lignan secoisolariciresinol diglucoside (SDG), which can be metabolized by the colonic 
microflora to yield the mammalian lignans, enterodiol (ED) and enterolactone (EL) 
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Fig. 8. The contents of compounds with potential biomedical applications in transgenic 
plants overexpressing genes from the phenylopropanoid pathway 
Phytoestrogens such as lignans, which exhibit weak estrogenic and antiestrogenic properties 
in a tissue-specific manner, have potential in the prevention and treatment of breast cancer 
(Adlercreutz, H. & Herman, 2002). Flax seeds and their lignans have been reported to inhibit 
chemically induced mammary tumorigenesis at the preinitiation, early, and late promotion 
stages of carcinogenesis in rats (Thompson et al., 1996), and the growth and metastasis of 
human breast cancer in nude mice (Chen et al., 2002). The last published evidence also 
suggests that a dose of at least 500 mg SDG/day for approximately 8 weeks is enough to 
observe positive effects on cardiovascular risk factors in human patients. Flax seeds and their 
lignan extracts appear to be safe for most adult populations (Adolphe et al., 2010). 
It is indicated that a diet rich in flavonoid compounds is strongly correlated with a lower 
risk of cancer (Ross and Kasum 2010). The compound with an especially higher anti-cancer 
action is quercetin, particularly in synergic action with keampferol (Brusselmans et al., 
2005). In both prostate and breast cancer cells, a remarkable dose-response parallelism was 
observed between the flavonoid-induced inhibition of fatty acid synthesis, the inhibition of 
cell growth, and the induction of apoptosis. The dose which caused a reduction of the cancer 
cell proliferation to 19% is 100 μM quercetin; 100 μM kaempferol caused a reduction to 32% 
(Brusselmans et al., 2005). 
3.2 Flax with elevated levels of terpenoids 
Terpenoids, also called isoprenoids, are group of about 40000 compounds. The group contains 
both primary and secondary metabolites of great significance for the growth and development 
of plants. Gibberellic acid, abscisic acid (phytohormons), carotenoids, chlorophyll, and 
ubiquinone can be distinguished among the primary metabolites (Aharoni et al., 2008). The 
classification of terpenoids is based on the number of 5-carbon isoprene units, which compose 
the backbone of the molecule. Hemi-, mono-, sesqui-, di-, tri- and tetraterpenes correspond to 
5-, 10-, 15-, 20-, 30- and 40-carbon terpenoids (Saremi and Arora, 2009). In plants, the isoprene 
units are produced from isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate 
(DMAPP), which may originate from different pathways (Fig. 9).  
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The mevalonate pathway occurs in the cytosol, and was discovered first. IPP synthesis 
begins with transformation of 2 molecules of acetyl-CoA to 3-Hydroxy-3-Methyl-Glutaryl-
CoA (HMG-CoA), which is subsequently converted by HMG-CoA reductase to mevalonate. 
The mevalonate undergoes phosphorylation to mevalonyl phosphate (catalysed by 
mevalonyl kinase), and then to mevalonyl diphosphate (catalysed by mevalonyl phosphate 
kinase). Isopentenyl pyrophosphate (IPP) is formed via the action of mevalonyl phosphate 
decarboxylase. This is next transformed by isopentyl isomerase to dimethylallyl 
pyrophosphate (DMAPP) (Siemieniuk & Skrzydlewska, 2005). It is suggested that this 
pathway is the source for 15- and 30-carbon terpenoids (squalene, sterols, brassinosteroids).  
The second, non-mevalonate pathway was discovered 10 years ago, and some of its steps 
are not fully known. It takes place in the plastids and is responsible for the synthesis of 10-, 
20- and 40-carbon terpenoids (gibberellins, carotenoids, chlorophyll, tocopherol). The 
substrates are pyruvate and glyceraldehyde 3-phosphate, which are converted by DXS 
synthase to 1-deoxy-D-xylulose 5-phosphate (DXP). DXP is then transformed by DXR 
reductase into methylerytritol phosphate (MEP). The final step is the reduction of MEP to 
isopentenyl phosphate (IPP) (Cheng et al., 2007). 
 
 
Fig. 9. The pathway of terpenoid biosynthesis 
In the second step of terpenoid synthesis, 5-carbon molecule IPP and DMAPP undergo 
condensation due to the activity of prenyltransferases. The combination of one IPP and one 
DMAPP molecule yields geranyl diphosphate (in a reaction catalysed by GDP synthase), 
which is a precursor for monoterpenes. Two IPP molecules associated with DMAPP are 
transformed to farnesyl diphosphate (catalysed by FDP synthase), which gives a 15-carbon 
precursor of sesquiterpenes and triterpenes. Three molecules of IPP connected to DMAPP 
give geranylgeranyl diphosphate (catalysed by GGDP synthase), which is a precursor of the 
20- and 40-carbon compounds. The last step of terpenoid synthesis comprises the 
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transformation of prenyl diphosphates (GDP, FDP and GGDP) by the appropriate terpenoid 
synthases (e.g. squalene synthase) (Cheng et al., 2007). 
In plants, terpenoids play mainly protective roles against various environmental stresses. 
Many of them possess antioxidative properties (carotenoids, tocopherols), bacterio- and 
mycostatic properties (menthol, camphor), and recently, anti-neoplastic and anti-
inflammatory properties are frequently reported (squalene, tocopherols, carotenoids, taxol) 
(Peltier et al., 2006). The ability to quench free radicals produced both during normal cell 
functioning, as well as under stress conditions, also contributes to the inhibition of many 
free radical-based diseases, including neoplasms (Grassmann, 2005; Gershenzon and 
Dudareva, 2007). The above-mentioned properties of terpenoids make them attractive 
dietary supplements.  
Stress, pollution, lack of movement and bad nutritional habits cause many diseases, 
including neoplasms. Pharmacies offer a plethora of vitamin preparations, but they are 
mainly composed of substances obtained via chemical synthesis. The newest results indicate 
that the assimilability of compounds obtained from natural sources is much higher. 
Therefore, instead of “swallowing” more pills, nutritionists advise the consumption of 
products rich in natural bioactive compounds. Without a doubt, linseed oil is such a 
product. It constitutes the main source of omega-3 and omega-6 fatty acids. A drawback of 
this oil is its lability, caused by the presence of highly unsaturated fatty acids. Enriching it in 
natural substances increases its stability (tocopherol, carotenoids) and improves its health-
oriented properties (squalene), expanding its potential for use in prophylaxis against many 
diseases, including diseases of the circulatory system and eyesight. This may make flax 
more competitive in relation to imported oils. An innovative product with a broad spectrum 
of action will result from such modifications.  
Carotenoids are a group of over 700 compounds of yellow or orange colour. The majority 
are tetraterpenes consisting of 8 isoprene units. The molecule consists of 40 carbon atoms. 
The human organism is unable to synthesize carotenoids, and thus must intake them with 
nutrients. Studies prove that a diet rich in these compounds, provided they are of natural 
origin, lowers the risk of several diseases, particularly neoplasms and eyesight diseases. The 
anti-cancer character of carotenoids is based on different mechanisms, such as their 
antioxidative activity, strengthening of the immunological system, stimulation of gap 
junction formation in intracellular communication, induction of detoxification enzymes, and 
inhibition of cell proliferation. The anti-cancer activity of carotenoids was mainly observed 
and studied in the case of lung cancer (ǃ-carotene), prostate cancer (lycopene), gullet and 
larynx cancer (lycopene), stomach cancer (lycopene), and leukemia (ǃ-carotene). 
Carotenoids are mainly accumulated in the testicles, epididymides and liver (mostly ǃ-
carotene and lycopene). Without a doubt, the best-known benefit of carotenoid intake is the 
fact that about 50% of them can be converted into vitamin A, and the most prominent pro-
vitamin activity is shown by ǃ-carotene. Vitamin A is transformed to retinen, which is an 
indispensable component of the retinal pigments, and which conditions normal sight. Intake 
of nourishment containing those carotenoids protects the retina from degradation and 
diseases connected with age (Johnson, 2002). 
Carotenoids are insoluble in water, but they dissolve very well in fats. The production of 
flax plants with an elevated carotenoid content was recently described (Fujisawa et al., 2008). 
Flax was successfully transformed with the phytoene synthase gene (crtB) derived from the 
soil bacterium Pantoea ananatis under the control of the constitutive cauliflower mosaic virus 
(CaMV) 35S promoter. The genetically modified flax produced orange seeds with a high 
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accumulation of phytoene, ǂ- and ǃ-carotene. The carotenoid amounts in the seeds reached 
63.4 to 156.3 µg/g of fresh weight, which was a 7.8 to 18.6-fold increase in comparison to 
non-transformed plants (Fujisawa et al., 2008). It is suggested that the flux of phytoene 
synthesis from geranylgeranyl diphosphate was first promoted by the expressed crtB gene 
product, and then the phytoene was decomposed to the downstream metabolites as ǂ- and 
ǃ-carotene and lutein. It is expected that oil obtained from the seeds of those plants will 
contain an elevated pool of carotenoids. This will improve the stability and quality of the oil, 
rich in highly unsaturated fatty acids. In vitro studies showed that the addition of ǃ-carotene 
to oils protects unsaturated fatty acids from oxidation. The oil is characterized with an 
elevated amount of vitamin A and lutein, and is a potential innovative product.  
Squalene is a triterpene obtained via the mevalonate pathway. It is also a precursor for 
cholesterol biosynthesis (Reddy and Couvreur, 2009). For commercial purposes, it is 
acquired mainly from shark liver oil, though there are also plants rich in this compound, e.g. 
amaranth seeds, rice bran, wheat germs and olives. Its direct anti-tumour activity is based 
on inhibiting the catalytic activity of ǃ-HMGCoA. Although it is a weak inhibitor of tumour-
cell proliferation, it contributes directly or indirectly to cancer treatment by strengthening 
the influence of antigens, which bind to it. Thus, it is widely used in vaccines and medicines 
(Kelly, 1999). Squalene diminishes the side effects of chemotherapy (Reddy and Couvreur, 
2009). In addition, it normalizes the level of cholesterol in blood. 
Introducing a gene of lycopene ǃ-cyclase from Arabidopsis thaliana to flax caused 
homological repression and lowered carotenoid content. At the same time, it redirected the 
substrates to produce the remaining terpenoids. The plants generated in this way turned out 
to be more resistant to Fusarium infection (unpublished data), which is an additional 
argument for the cultivation of this transgenic type. 
Through the repression of carotenoid synthesis, flax with an elevated squalene content was 
obtained (Table 1). The seeds of the transformed flax (L plants) are richer in squalene (data 
not published). An important aspect of this modification is not only that plants rich in a 
health-oriented compound are obtained, but also that a new strategy can be proposed for 
the modification of the metabolism in a preferred direction via repression of a pathway or 
pathways which are not desired. This strategy is justified by the fact that repression of a 
gene in plants is much easier than its activation, as only a short DNA fragment (100-200 bp) 
homologous to the endogenous gene is required. 
 
Terpenoid Linola L9 L18 
Squalene 100% 80% 192%
Tocopherol alpha 100% 136% 217%
Tocopherol beta 100% 170% 818%
Gibberellic acid GA3 100% 85% 182%
Menthol 100% 156% 141%
β-carotene 100% 62,5% 50% 
lutein 100% 98% 80% 
Table 1. Percentage level of different terpenoids in flax plants with repression of lycopene 
beta cyclase gene (named L) 
www.intechopen.com
Flax Engineering for Biomedical Application 
 
423 
3.3 Modified flax oil as a precious source of unsaturated fatty acids 
An increasing coefficient of morbidity of civilization diseases such as obesity, 
atherosclerosis, heart disease and hypertension was observed with the development of 
industry and the economy. The Western diet is characterized by high intakes of animal fat, 
saturated acids, omega-6 acids, and trans-fatty acids, and this contributes to civilization 
diseases. The consumption of flax seeds is suggested to be beneficial for human health. Flax 
seeds have about 40% fat in dry weight (Łukaszewicz et al., 2004). Linseed oil consists of 
about 16% linoleic acid and 54% linolenic acid, and is the richest source of these 
polyunsaturated fatty acids (PUFA), (Table 2). 
 
Fatty acids Olive oil
Rapeseed 
oil 
Soybean 
oil 
Sunflower 
oil 
Corn oil Grapeseed oil Linseed oil 
14:0 0 0 0.11 0.08 0 0 0 
16:0 11.46 4.68 10.62 6.66 10.1 6.79 5.06 
16:0 0.96 0 0.09 0.08 0 0.10 0 
18:0 2.20 2.36 3.76 4.27 1.6 3.63 3.73 
18 : 1 n-9 68.76 57.14 21.67 24.2 31.4 17.8 19.68 
18 : 1 n-7 0 3.40 1.61 0.58 0 0 0.68 
18 : 2 n-6 10.51 21.16 55.07 63.65 56.3 65.9 16.21 
18 : 3 n-3 0.67 11.25 6.89 0.19 0.4 0.38 54.52 
Table 2. The fatty acid composition of seed oils (%) in different plant oils 
(http://www.biuletynfarmacji.wum.edu.pl/0501Jelinska/0Jelinska.html) 
PUFA are divided into two main groups: omega-6 and omega-3. Their precursors are 
linoleic (LA) and ǂ- linolenic acids (ALA), respectively. LA and ALA are numbered among 
essential fatty acids because they cannot be synthesized in mammals. LA and ALA 
delivered in food play an important role in the correct development and functioning of the 
human body. They are structural components of the cell membranes and substrates in the 
biosynthesis pathway of arachidonic acid (AA), eicosapentaenoic acid (EPA), 
docosahexaenoic acid (DHA), and their eicosanoids (Fig. 10). Biosynthesis of omega-6 and 
omega-3 fatty acids is catalyzed by the same enzymes. Through the conversion by 
desaturase and elongase enzymes, LA is transformed to arachidonic acid (AA), and ALA to 
eicosapentaenoic acid (EPA), and then to docosahexaenoic acid (DHA). Supplementing the 
diet with ALA promotes the omega-3 pathway, leading to the inhibition of synthesis of 
arachidonic acid and eicosanoids derived from AA, which stimulate inflammation (Muir 
and Westcott, 2003).  
Numerous epidemiological and experimental studies have shown the positive effects of 
omega-3 fatty acids on the reduction in risk of cardiovascular disease, stroke and 
atherosclerosis. They revealed anti-cancer and anti-inflammatory activities (Saravanan et al., 
2010).  
PUFAs, especially ǂ- linolenic acid, are susceptible to oxidation, which causes a change in 
taste and odour, and causes problems with long-term storage. A mutation in the FAD3 
genes, responsible for the conversion of linoleic acid to linolenic acid in flax, was achieved in 
order to minimize the oxidation processes. This led to a new type of flax seeds, described as 
the solin type (low ǂ- linolenic acid content), which are suitable for the production of edible 
oil (Rowland, 1991). The mutation induced with methane sulphonate (EMS) resulted in a 
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stable low linolenic acid mutant. The low linolenic character is controlled by recessive alleles 
at two independent loci, which are the result of a double mutation. 
  
Omega-6
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Omega-3
Oleic acid (OA)
18:1
Linoleic acid (LA)
18:2
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 (18:3)
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20:4
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Fig. 10. The metabolic pathway of polyunsatured fatty acids. Linoleic acid and alpha- 
linolenic acid are the respective parents for the omega-6 and omega-3 fatty acids. They are 
synthesized in flax seeds by desaturation catalysed by a set of enzymes coded by the FAD2 
and FAD3 genes  
During the cold extraction of oil most of the natural antioxidants are lost. It is desirable to 
find a technology of oil production with improved oxidative protection. One possibility is 
oil supplementation with natural antioxidants. This supplementation was performed on flax 
seeds via various transgenic modifications. One of these modification was transformation 
with the Solanum sogarandinum-derived gene (designated SsGT1) coding for 
glycosyltransferase (UGT) under a seed-specific napin promoter. UGTs are large group of 
enzymes found in all living organisms which catalyse the transfer of a nucleotide 
diphosphate-activated monosaccharide unit (glucose, rhamnose, galactose, xylose, rutinose, 
and neohesperidose) to an acceptor molecule. Plant UGTs play a role in developmental and 
metabolic homeostasis, and also take part in detoxification processes. It is known that the 
glycosylation of low molecular weight compounds such as flavonoids makes the molecules 
more stable, increases their solubility in the vacuole, and can enhance the pathogen 
resistance of plants. Flax plants overexpressing SsGT1 accumulated higher levels of 
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glucosylated flavonoids in the seeds, mainly the kaempferol and quercetin glycoside 
(Lorenc-Kukuła et al., 2009). Overproduction of SsGT1 in transgenic flax (named UGT 
plants) also resulted in proanthocyanin, phenolic acid and unsaturated fatty acid 
accumulation in the seeds. The linseed oil of UGT plants was examined via gas 
chromatography, which revealed an increase in unsaturated 18:1 (11-14%), 18:2 (9.5-24.7%), 
and 18:3 (23.7-54.5%) fatty acids.  The antioxidant compounds are hydrophilic in nature. 
They accumulated in seeds, partially cross to the oil phase. Moreover, their level changes 
during the oil purification processes and remains the highest if cold-oil pressing is used. 
Various hydrophilic and hydrophobic compounds can stabilize linseed oil depending on 
their concentration, structure and proportions. The antioxidant compounds found in UGT 
plants were able to improve oil storage. It was observed that the rate of conjugated diene 
and aldehyde formation in the heated oils from transgenic seeds was lower than in the oil of 
the control plants (data not published). A similar positive effect on oil storage was achieved 
in flax oil derived from plants overexpressing three genes of the flavonoid route: chs, chi and 
dfr. As described in section 2.1 (Manipulation of flax genes of phenylopropanoid pathway), 
W92 transgenic flax was characterised by an elevated level of flavonoids and by an 
increased antioxidant capacity of the seeds (Lorenc-Kukuła et al., 2007). The accumulation of 
antioxidants in W92 plants had a positive effect on oil storage (Prescha et al., 2008). 
Among the fatty acids that belong to the omega-3 group, EPA and DHA have beneficial 
effects on health. These PUFAs mostly occur in fish oil, but a drop in the quantity, and the 
contamination of this source has been continuously observed. A diet rich in ALA elevates 
erythrocyte EPA and DPA concentration in humans (Barceló-Coblijn et al., 2008). Another 
alternative was the expression of enzymes, such as Δ6-desaturase, Δ6-elongase, and Δ5-
desaturase, which participate in biosynthesis of very-long-chain polyunsaturated fatty acids 
in flax. In spite of the high level of accumulation of C18 desaturated fatty acids, these 
products were channeled to triacyloglycerols, which led to a lack of substrates for Δ6-
elongase. Only 5% C20 polyunsaturated fatty acids were obtained (Abbadi et al., 2004).   
The oxidative stability of linseed oil is still the main goal to achieve. The high production 
and accumulation of very long-chain polyunsaturated fatty acids in linseed oil, especially 
EPA and DHA, is the next challenge. 
Variation in oil lipid composition of the different flax cultivars is presented in Table 3. 
It is worth mentioning the geometric and positional isomers of linoleic acid, the conjugated 
linoleic acids (CLA). The main sources of CLA are dairy products and the fat tissue of  
ruminant animals. Studies indicate that CLA has anti-cancer, anti-atherosclerotic, anti-
diabetic, anti-inflammatory, and anti-obesity activities (Wahle et al., 2004). Linseed oil is still 
underestimated as a valuable source of compounds that are beneficial for human health. The 
wide range of action of polyunsaturated fatty acids make linseed oil a desirable and helpful 
product in medical treatment. 
3.4 New anti-inflammatory and analgesic compounds derived from flax 
The most recent studies on flax products’ properties have revealed many health-beneficial 
actions in aspects of different diseases. One of the latest investigated activities is the anti-
inflammatory nature of flax plant and product extracts. This aspect of the flax plant studies 
was based on promising results of flax bandage use in the healing of chronic wounds of 
different etiologies. The direct reasons for chronic ulcerations are always connected to the 
inflammation state of the organism, so inflammation-related processes are very important in 
wound healing.  
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Cultivar/fatty acid 16:0 18:0 18:1 18:2 18:3 20:0 
Voroezski 6.11 4.6 22.0 14.9 52.2 0.24 
Jenny 6.91 5.7 19.7 14.2 52.1 0.36 
La Estanzuela AR 6.28 4.1 17.7 14.1 57.5 0.46 
Opal 5.43 3.73 18.2 15.3 56.1 1.22 
Szafir 5.19 3.28 14.1 11.9 65.4 0.11 
Abby 5.99 3.4 13.3 18.2 58.9 0.11 
Linola 6.28 1.91 13.5 74.5 3.27 0.28 
W92.40 6.03 3.37 15.94 70.92 2.25 0.14 
W92.86 5.85 4.74 21.98 41.71 24.54 0.18 
UGT/NAP 6.30 3.85 17.96 69.07 1.43 0.12 
Table 3. Variation in oil lipid composition of the different flax cultivars (Łukaszewicz et al, 
2004; Lorenc-Kukuła et al,2004; Lorenc-Kukuła et al, 2009) 
There are many groups of compounds that can be partially responsible for flax bandage 
anti-inflammatory action, for example the previously mentioned groups of antioxidants, 
directly regulating the oxidation processes connected to inflammation. Among the different 
types of molecules, we chose the terpenophenols for further investigation, as some very 
interesting ones have recently been found in flax extracts. The new compound identification 
is based on UPLC retention time, UV spectra and GC-MS analysis in comparison to some 
terpenophenolic standards. The identification is still of a preliminary nature, but all the 
methods used confirm the presence of cannabinoid-like compounds in the examined 
extracts (results not published). Cannabinoids have never previously been discovered in any 
plants other than cannabis plants, so these results are very intriguing and interesting. 
Cannabinoids are a group of terpenophenolics that accumulate in considerable amounts in 
the glandular trichomes of Cannabis sativa (Cannabaceae). In cannabis plants, the 
biosynthesis of these terpenoids involves a common isoprenoid building block, isopentenyl 
diphosphate, while the biosynthesis of the phenyl part of the cannabinoid, olivetolic acid is 
connected to the polyketide pathway. Further alkylation of olivetolic acid with geranyl 
pyrophosphate leads to the formation of cannabigerolic acid (CBGA), the central precursor 
of various cannabinoids like tetrahydrocannabinol (THC), cannabidiol (CBD) or 
cannabichromene (CBC) (Sirikantaramas et al., 2007). The synthesis pathway of 
cannabinoids in cannabis plants is presented in Figure 11. All the precursors for the 
biosynthesis are present at relatively high levels in flax plants, so a similar pathway of 
synthesis is possible. Investigations of the activity of such a biosynthesis pathway are in 
progress, but there is still no evidence of its existence in flax. 
The special properties of cannabinoids have been known and exploited for thousands of 
years for medical purposes, mainly as anti-inflammatory and pain- realising agents. There 
are many studies nowadays providing evidence for the biological activity of these 
compounds in pain relief and healing of many kinds of diseases, including neuropatic pain, 
multiple sclerosis, Alzheimer's disease, atherosclerosis, rheumatoid arthritis, asthma, many 
allergies and other inflammatory diseases including AIDS (Pacher et al., 2006). The 
inflammation state plays a crucial role in all the mentioned health issues and cannabinoids 
have been proven to have an influence on this process. Activation of specific cannabinoid 
receptors (CB1 and/or CB2) and the downstream signaling cascade inhibits the production  
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Fig. 11. The synthesis pathway of cannabinoids in cannabis plants 
of cytokines and activates anti-inflammatory protein expression (Klein et al., 2000). The 
process of inflammation inhibition is presented in Fig. 12. This system, as the main target in 
new flax application, was the focus of examinations of the biological activity of the flax 
extracts containing cannabinoid-like compounds. 
Real-Time PCR expression measurements of common cytokines level in both mouse and 
human fibroblast cell line experiments showed the inhibition of pro-inflammatory gene 
expression after flax cannabinoid-like extract treatments (results not published). Biological 
activity assays of the newly discovered compounds still need to be confirmed in many 
aspects, but the first results are very promising. 
The existence, nature, biosynthesis pathway and activity of cannabinoids in flax requires 
much further investigation, but the discovered compounds give great new possibilities for 
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flax product applications. The experiments in this field will give the opportunity for 
manipulations of the type and level of the compounds produced, which would be of great 
significance in the medical application of the natural non-psychoactive anti-inflammatory 
and pain-relieving products derived from flax. 
 
 
 
Fig. 12. The process of inflammation inhibition by cannabinoids through CB receptor 
4. Conclusion 
The interest in the medicinal, nutraceutical and industrial value of flax is still growing. The 
utility of this crop plant is not only restricted to edible oil and textile fibre production. 
Genetic manipulation enabled its use to be broadened in many fields, but mainly in 
medicine and human health. The research is not only focused on unsaturated fatty acids but 
also on precious antioxidants such as phenylopropanoids, lignans and terpenoids. Many 
new transgenic lines of flax characterized by better properties of fibre and oil have been 
generated. Genetic engineering methods allow the manipulation of the desired genes to 
improve the traits of flax. As the transformation protocol of flax is well established and the 
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results are very promising, it is clear that genetically modified flax has a future in medical 
applications. 
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